有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Elocalcitol;Ro-26-9228;BXL-628
Chemical Name (23E)-1alpha-Fluoro-25-hydroxy-16,17,23,24-tetradehydro-26,27-bishomo-20-epivitamin D3
CAS 199798-84-0
Related CAS
Formula C29H43FO2
Structure
Formula Weight 442.66326
Stage II 期临床
Company Roche Bioscience (Originator)
Activity/Mechanism Bone Diseases, Treatment of, METABOLIC DRUGS, Treatment of Osteoporosis, Vitamin D Analogs
Syn. Route 2
Route 1
the indenone intermediate (xiii) has been obtained as follows: the silylation of 3-methyl-1-pentyn-3-ol (i) with tes-cl and dmap in dmf gives the silyl ether (ii), which is condensed with paraformaldehyde and n-buli in thf to yield the propargyl alcohol (iii). partial reduction of (iii) with red-al in thf affords the allyl alcohol (iv), which is treated with ts-cl and dmap in dichloromethane to provide the allyl chloride (v). the condensation of (v) with the unsaturated ester (vi) (obtained by wittig condensation of perhydroindanone (vii) with triethyl phosphonoacetate (viii) by means of etona) by means of buli and dicyclohexylamine in hmpa gives the octenoic ester (ix), which is reduced with lialh4, yielding the corresponding primary alcohol (x). the reaction of (x) with tscl and pyridine affords the tosylate (xi), which is reduced with libet3h in thf with simultaneous opening of the epoxide ring to provide the hexahydroindenol (xii). finally, this compound is oxidized with pyridinium dichromate (pdc), yielding the target hexahydroindenone intermediate (xiii).
List of intermediates No.
methyl (1r,2r)-1-hydroxy-7-methoxy-1,2,3,4-tetrahydro-2-naphthalenylcarbamate (viii)
ethyl 2-[7-fluoro-2,3-dioxo-3,4-dihydro-1(2h)-quinoxalinyl]acetate (vii)
4-{[tert-butyl(diphenyl)silyl]oxy}-3-[(methylsulfonyl)amino]phenyl acetate (i)
tert-butyl 2-{[tert-butyl(diphenyl)silyl]oxy}-5-hydroxyphenyl(methylsulfonyl)carbamate (ii)
tert-butyl 2-{[tert-butyl(diphenyl)silyl]oxy}-5-[(2s)oxiranylmethoxy]phenyl(methylsulfonyl)carbamate (iii)
1,4-difluoro-2-(isocyanatomethyl)benzene; 2,5-difluorobenzyl isocyanate (iv)
tert-butyl 4-[(1-{[(2,5-difluorobenzyl)amino]carbonyl}-4-piperidinyl)amino]phenethylcarbamate (v)
4-[4-(2-aminoethyl)anilino]-n-(2,5-difluorobenzyl)-1-piperidinecarboxamide (vi)
3-[(12r,13r,22s,23s)-17-acetyl-12-ethyl-13,18,22,27-tetramethyl-3,5-dioxo-4-oxa-8,24,25,26-tetraazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoic acid (ix)
propyl 3-[(12r,13r,22s,23s)-17-acetyl-12-ethyl-13,18,22,27-tetramethyl-3,5-dioxo-4-oxa-8,24,25,26-tetraazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (x)
methyl (9r,10r,19s,20s)-14-acetyl-9-ethyl-2-[(hexylamino)carbonyl]-5,10,15,19-tetramethyl-20-(3-oxo-3-propoxypropyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1~3,6~.1~8,11~.1~13,16~]tetracosa-1,3,5,7,11(23),12,14,16,18(21)-nonaene-4-carboxylate (xi)
methyl (9r,10r,19s,20s)-14-acetyl-9-ethyl-4-[(hexylamino)carbonyl]-5,10,15,19-tetramethyl-20-(3-oxo-3-propoxypropyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1~3,6~.1~8,11~.1~13,16~]tetracosa-1,3,5,7,11(23),12,14,16,18(21)-nonaene-2-carboxylate (xii)
propyl 3-[(12r,13r,22s,23s)-17-acetyl-12-ethyl-4-hexyl-13,18,22,27-tetramethyl-3,5-dioxo-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xiii)
Reference 1:
    radinov, r.n.; daniewski, a.r. (f. hoffmann-la roche ag); process for preparing anti-osteoporotic agents. ep 1048661; jp 2000336094 .

Route 2
the reaction of the cyclohexylidene ethanol (xiv) with triphosgene gives the corresponding chloride (xv), which is condensed with diphenylphosphine oxide (xvi) by means of nah in dmf to yield the alkyldiphenylphosphine oxide (xvii) (2). the condensation of (xvii) with the hexahydroindenone intermediate (xiii) by means of buli in thf affords the disilylated precursor (xviii), which is finally deprotected by means of tbaf in thf.
List of intermediates No.
propyl 3-[(12r,13r,22s,23s)-17-acetyl-12-ethyl-4-hexyl-13,18,22,27-tetramethyl-3,5-dioxo-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xiii)
propyl 3-[(12r,13r,22s,23s)-12-ethyl-4-hexyl-17-(1-hydroxyethyl)-13,18,22,27-tetramethyl-3,5-dioxo-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xiv)
propyl 3-[(12r,13r,22s,23s)-17-(1-bromoethyl)-12-ethyl-4-hexyl-13,18,22,27-tetramethyl-3,5-dioxo-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xv)
propyl 3-[(12r,13r,22s,23s)-12-ethyl-4-hexyl-13,18,22,27-tetramethyl-3,5-dioxo-17-vinyl-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xvii)
4-(3-bromopropyl)-2,6-di(tert-butyl)phenol (xviii)
2,6-di(tert-butyl)-4-[3-(4-nitrophenoxy)propyl]phenol (xvi)
Reference 1:
    batcho, a.d.; bryce, g.f.; hennessy, b.m.; iacobelli, j.a.; uskokovic, m.r. (f. hoffmann-la roche ag); vitamin d3 analogs. ep 0808833; jp 1998045713; us 5939408 .
Reference 2:
    kabat, m.m. (f. hoffmann-la roche ag); phosphinoxide vitamin d precursors. ep 1050537 .

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名艾洛骨化醇;英文名Elocalcitol;Ro-26-9228;BXL-628;CAS[199798-84-0]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
呋虫胺和烯啶虫胺继续扩作
华南地区环氧丙烷市场稳定
华东地区丁二烯市场盘整
丰山集团正式挂牌,发行首日秒封
苯胺跌势难改
损失或超6千万!这家上市公司被
山东地区环氧丙烷市场稳定
丙炔氟草胺领军“其他PPO抑制
华北地区醋酸价格整体上调
吡丙醚和氟啶虫酰胺继续扩作
红太阳子公司南京生化完成增资工
嘧菌胺获欧盟批准开展再评审,但
新型“超分子纳米囊”可减少农药
PTA 回调为主
醋酸市场供需平衡
华中地区甲苯行情暂稳
东北地区甲苯行情暂稳
新增一家毒氟磷制剂登记企业
装置集中检修 丁酮强势上涨难持
关于农药登记有关行政许可办理系
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明